EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Preoperative Radiotherapy (Preop-RT) Improves Pathological Complete Response Rates in Partial Responders (PR) to Primary Systemic Chemotherapy (PST) in Locally Advanced Breast Cancers (LABC)

Präoperative Radiotherapie (Preop-RT) verbessert die pathologischen Komplettremissionsraten bei partiellen Responder:innen auf eine primäre systemische Chemotherapie bei lokal fortgeschrittenen Mammakarzinomen

Sushma Agrawal, Anshika Gupta, Gyan Chand

South Asian Journal of Cancer · 01.07.2025 · 14 (03) · 508-516

DOI: 10.1055/s-0045-1809176 ↗

Auf einen Blick

In einer Pilotstudie erreichten partielle Responder:innen auf eine primäre systemische Chemotherapie unter Preop-RT häufiger eine pathologische Komplettremission. Die Studie berichtet ermutigende Ergebnisse in Hochrisikogruppen.

Fragestellung

Verbessert Preop-RT bei partiellen Responder:innen auf primäre systemische Chemotherapie die pathologische Komplettremissionsrate bei lokal fortgeschrittenem Brustkrebs?

Methode

Pilotstudie mit 21 Frauen; nach 2 Taxan-Zyklen Preop-RT und danach Fortsetzung der Chemotherapie; primärer Endpunkt ypCR.

Ergebnisse

21 Frauen wurden eingeschlossen. ypCR(T) betrug 53 % und ypCR(N) 59 %. ypCR(T) lag bei 50 % bei Her-2-positivem, 25 % bei TNBC und 33,3 % bei luminal A.

Schlussfolgerung der Autor:innen

Die Autor:innen berichten ermutigende Ergebnisse in Hochrisikogruppen und sehen das Potenzial von Preop-RT als weiter zu untersuchend.

Kernaussagen

  • Pilotstudie bei 21 Frauen mit lokal fortgeschrittenem Brustkrebs
  • ypCR(T) 53 % und ypCR(N) 59 %
  • Weitere größere Studien zur Prüfung von Preop-RT empfohlen

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift South Asian Journal of Cancer, erschienen am 01.07.2025. Verfasst von Sushma Agrawal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Radiotherapy, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Preoperative radiotherapy (preop-RT) can be used as one strategy to improve pathological complete response rates in locally advanced breast cancer. Hence, we conducted a pilot study of preop-RT in partial responders to primary systemic chemotherapy (PST). Standard PST comprising of four cycles of Adriamycin/cyclophosphamide followed by four cycles of taxanes (along with trastuzumab in Her2-neu enriched) was initiated. After two cycles of taxanes, partial responders (PRs) were enrolled onto preop-RT (40 Gy/15#/3 weeks to whole breast followed by boost dose of 10 Gy/4#/1 week to gross tumor with 5 mm margin [clinical target volume] and 10 mm margin [planning target volume] by three-dimensional conformal radiation therapy. Field-in-field technique was used whenever the need to correct dose heterogeneity arose. The remaining two cycles of taxanes were completed 3 weeks after the completion of RT. Surgical intervention was initiated 6 weeks after the completion of PST. The intention of such a strategy was to keep an interval of 12 weeks between completion of RT and surgery to achieve maximum downstaging. The primary endpoint was pathological complete response rate (ypCR). Twenty-one women were enrolled (median age 47 years, 35% premenopausal, 50% upper outer quadrant, 65% T4, 85% node positive, 40% luminal A, 10% luminal B, 15% Her-2-neu enriched, and 35% triple-negative breast cancer [TNBC]). Twenty-eight percent underwent breast conservation and the rest modified radical mastectomy (n = 13) and 2 did not undergo surgery (elderly [n = 1], lost to follow-up [n = 1]). ypCR(T) rate was 53% and ypCR(N) was 59%. ypCR(T) rate was 50% in Her-2 positive and 25% in TNBC, and 33.3% in luminal A. At a median follow-up of 24 months, the median overall survival is 41 months and 2 (both TNBC, ypCR, and ypPR) developed distant metastasis (in lung and soft tissue). This pilot study reveals encouraging results in high-risk subsets and this potential of preop-RT should be explored further in larger studies.

Schlagwörter

Stichwörter der Autor:innen

locally advanced breast cancerneoadjuvant chemotherapypathological complete responsepreoperative radiotherapy

Autor:innen und Institutionen

  • Departments of Radiotherapy, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
  • Departments of Endocrine Surgery, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.

Zitieren

APA

Agrawal, S., Gupta, A., & Chand, G. (2025). Preoperative Radiotherapy (Preop-RT) Improves Pathological Complete Response Rates in Partial Responders (PR) to Primary Systemic Chemotherapy (PST) in Locally Advanced Breast Cancers (LABC). South Asian Journal of Cancer, 14(03), 508-516. https://doi.org/10.1055/s-0045-1809176

Vancouver

Agrawal S, Gupta A, Chand G. Preoperative Radiotherapy (Preop-RT) Improves Pathological Complete Response Rates in Partial Responders (PR) to Primary Systemic Chemotherapy (PST) in Locally Advanced Breast Cancers (LABC). South Asian Journal of Cancer. 2025;14(03):508-516. doi:10.1055/s-0045-1809176

BibTeX
@article{Agrawal2025,
  author = {Agrawal, Sushma and Gupta, Anshika and Chand, Gyan},
  title = {Preoperative Radiotherapy (Preop-RT) Improves Pathological Complete Response Rates in Partial Responders (PR) to Primary Systemic Chemotherapy (PST) in Locally Advanced Breast Cancers (LABC)},
  journal = {South Asian Journal of Cancer},
  year = {2025},
  volume = {14},
  number = {03},
  pages = {508--516},
  doi = {10.1055/s-0045-1809176}
}
Kostenlos starten →